医学
病理生理学
缺血
再灌注损伤
心脏病学
内科学
重症监护医学
作者
Charles D. Collard,Simon Gelman
出处
期刊:Anesthesiology
[Lippincott Williams & Wilkins]
日期:2001-06-01
卷期号:94 (6): 1133-1138
被引量:637
标识
DOI:10.1097/00000542-200106000-00030
摘要
ISCHEMIA contributes to the pathophysiology of many conditions faced by anesthesiologists, including myocardial infarction, peripheral vascular insufficiency, stroke, and hypovolemic shock. Although restoration of blood flow to an ischemic organ is essential to prevent irreversible cellular injury, reperfusion per se may augment tissue injury in excess of that produced by ischemia alone. For example, the histologic changes of injury after 3 h of feline intestinal ischemia followed by 1 h of reperfusion are far worse than the changes observed after 4 h of ischemia alone. Cellular damage after reperfusion of previously viable ischemic tissues is defined as ischemia–reperfusion (I-R) injury. Ischemia–reperfusion associated with thrombolytic therapy, organ transplantation, coronary angioplasty, aortic cross-clamping, or cardiopulmonary bypass results in local and systemic inflammation. If severe enough, the inflammatory response after I-R may result in the systemic inflammatory response syndrome or multiple organ dysfunction syndrome (MODS), which account for 30–40% of the mortality in tertiary referral intensive care units. Thus, I-R injury may extend beyond the ischemic area at risk to include injury of remote, nonischemic organs.
科研通智能强力驱动
Strongly Powered by AbleSci AI